US Operations

A multi-state player with a growing presence
ARIZONA
Forecast Medical Market
 US$681M by 2020
  • Three Health for Life dispensaries; two currently fully operational with third slated to open shortly
  • The Holistic Center
MASSACHUSETTS
Forecast Recreational Market
 US$1b by 2020
  • Construction of first of three dispensaries underway
  • Cultivation and processing facility in Falls River under construction
NEVADA
Forecast Recreational Market
 US$630 by 2020
  • Operates fully licensed cultivation, production and wholesale cannabis business GreenMart
MARYLAND
Forecast Medical Market
 US$130M by 2020
  • Managing three dispensaries and one (not yet operational) production facility
  • Options to acquire each facility
We’re pursuing a multi-state strategy in the U.S., replicating our successful Arizona operations to expand via organic growth and a roll-up strategy.
scalableicon_07

Scalable

MPX Bioceutical Corporation’s operations are fully scalable, and will allow the company to increase production in sync with consumer demand and exploit economies of scale

proprietaryicon_09

Proprietary

MPX Bioceutical Corporation has access to both generic and proprietary plant varieties to unique products with varying CBD and THC levels

technologyicon_11

Technology

MPX Bioceutical Corporation has access to production techniques and technologies that increase production yields and lower costs

Canadian Operations

Getting ready for recreational legalization in July 2018
buildingicon_07

MPX Bioceutical Corporation is developing a 72,342 square foot production facility in Owen Sound, Ontario. Future expansion allows for up to an additional 402,658 square feet for a total of 475,000 square feet.

weedicon_09

Once complete, and fully operational, the facility will produce approximately 17,700 lbs (8045 kg) per year of dried flower and 700 lbs (317 kg) of concentrate from byproduct trim.

2018icon_11

MPX Bioceutical Corporation anticipates being ready to begin cultivation at its Owen Sound, Ontario facility in the second half of 2018.

CANADIAN SECURITIES EXCHANGE: MPX

MPX Bioceutical Corporation CEO Scott Boyes speaks with The Wall Street analyzer in this podcast on the company’s recent financial results and growth strategy

MPX Q3 Investor Call: March 8, 2018

MPX Bioceutical Corporation is looking to replicate the success at its revenue-generating U.S. operations in Canada. It has applied for a license from Health Canada. 
FINANCIALS

adobe_pdf_file_icon_24x24 FS
Q3 2018

adobe_pdf_file_icon_24x24 MD&A
Q3 2018

adobe_pdf_file_icon_24x24 FS
Q2 2018

adobe_pdf_file_icon_24x24 MD&A
Q2 2018

adobe_pdf_file_icon_24x24 FS
Q1 2018

adobe_pdf_file_icon_24x24 MD&A
Q1 2018

Management

SCOTT BOYES
Chairman, Chief Executive Officer and President

Chief Executive Officer Scott is a seasoned senior executive with diversified and cross-functional experience, combining MBA credentials with a strong career background in revenue development and general management.

DAVID MCLAREN
Chief Financial Officer

David has over 25 years years of senior financial experience, with the past ten spent at the CFO level. He has held positions at Ontario Drive & Gear Limited, Belmont Meats Limited, Redpath Sugar and Nealanders Limited. He holds a Honours Bachelor of Commerce degree from McMaster University and is a CPA.

BETH STAVOLA
Chief Operating Officer

Beth Stavola is also the Founder and CEO of Stavola Medical Marijuana Holdings, Health for Life Inc, GreenMart of Nevada, and CBD For Life, thriving cannabis businesses that process, grow and dispense throughout locations in both Arizona and Nevada. Before entering the cannabis space, Beth was Senior Vice President of Institutional Equity Sales at Jefferies New York.

MARK KRYTIUK
Vice President Grow Operations

Mr. Krytiuk is currently involved with two growing facilities that operate under MMAR in Ontario.

MICHAEL ARNKVARN
Executive Vice President Sales & Marketing

Michael Arnkvarn has an extensive management background in the operation of small to medium businesses since his graduation from McGill University in 1977 with a BSc in Agricultural Sciences.

SHAY SHNET
VP of Operations & Admin

Shay Shnet has extensive experience with over 12 years directly involved with the importing, packaging and distribution of a wide variety ofl product lines, including clothing, electronics, skin care and frozen foods.

JEREMY S. BUDD
General Counsel

Jeremy S. Budd, lawyer and founder of Budd Law, has been practising corporate and securities law in Toronto, Ontario since 2007. Mr. Budd represents issuers and underwriters in a wide variety of capital market transactions. Mr. Budd obtained his J.D./M.B.A. from Osgoode Hall, Law School and the Schulich School of Business at York University in 2005 and holds a Bachelor of Arts in philosophy from Huron University College at the University of Western Ontario.

JONATHAN CHU
Vice President Accounting

Jonathan Chu has a strong track record in financial management having held various senior financial accounting positions.  Jonathan holds a CPA, CA and a B.Comm from McGill University.

Board of Directors

SCOTT BOYES

Scott Boyes is a seasoned senior executive with diversified and cross-functional experience, combining MBA credentials with a strong career background in revenue development and general management.

RANDY STAFFORD

Randy has extensive experience in finance & operations, centered in the Financial services, real estate and nutraceutical sectors. He has previously served as the CFO of the MPX Bioceutical Corporation and has experienced first handed the evolution of the company. He is presently self-employed and is a CPA, CMA along with a MBA from the University of Toronto.

BETH STAVOLA

Beth Stavola is the Founder and CEO of Stavola Medical Marijuana Holdings, Health for Life Inc, GreenMart of Nevada, and CBD For Life, thriving cannabis businesses that process, grow and dispense throughout locations in both Arizona and Nevada. Before entering the cannabis space, Beth was Senior Vice President of Institutional Equity Sales at Jefferies New York.

ANDREW R. RYAN

Andrew Ryan has been General Counsel and a member of the Executive Committee at Holtec International since 2014.

Andrew is responsible for all legal matters affecting Holtec and its subsidiaries as well as insurance and risk management oversight, regulatory compliance, human resources and corporate administration. Prior to joining the executive team of Holtec, Mr. Ryan was an attorney with Lauletta Birnbaum, LLC.

SENATOR RICHARD S. “TICK” SEGERBLOM

Senator Tick Segerblom, State Senator of the Nevada State Senate since November 2012, is widely recognized as a leading legislator in Nevada, and the United States, in the medical and recreational marijuana fields.

Senator Segerblom, age 69, authored Nevada’s 2013 Medical Marijuana law and was Co-Chair of the successful 2016 ballot initiative campaign which approved recreational marijuana in the state.

ROBERT R. GALVIN

Robert Galvin has been CFO and Senior VP of Finance and Administration at Holtec International, an energy technology company, since 2016.

Prior to joining Holtec, Robert served as CFO of several companies, including NuCO2, a NASDAQ company providing bulk CO2 equipment and services. Mr. Galvin is experienced with mergers & acquisitions, debt and equity financings, and SEC compliance. He is a CPA, a Director and Audit Chair for OneSource Water, and a Director and former Stewardship Chair for the New Jersey Juvenile Diabetes Research Foundation.

DR. MILES D. THOMPSON

Dr. Thompson, Ph.D., Project Scientist at Department of Pediatrics, University of San Diego, California since 2016, will advise and assist with the development of cannabinoid-based nutraceutical products. Dr. Thompson served as a Clinical Research Associate at North York General Hospital in Toronto and initiated the study of cannabinoids in epilepsy at the Department of Pharmacology and Toxicology at the University of Toronto. He has extensive experience in the design and implementation of clinical trials administered by Health Canada.